The Harvard Drug recalls
4 federal recalls on file, showing the 3 from the last 12 months. We read every CPSC, FDA, USDA and NHTSA notice for The Harvard Drug and put it in plain English.
Recent recalls
Major Pharmaceuticals Methylergonovine Maleate recalled for subpotencyMAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.
ModerateFDAJul 1, 2026
- Major Pharmaceuticals memantine capsules recalled for failed dissolution
Major Pharmaceuticals is recalling memantine hydrochloride extended-release 7 mg capsules (lot N02425, expiring 05/31/2027) because the capsules may not dissolve properly in the body. This means the medication may not work as intended. The affected capsules were distributed nationwide.
ModerateFDAApr 22, 2026
- Major Pharmaceuticals midodrine tablets recalled for packaging defect
Major Pharmaceuticals is recalling midodrine hydrochloride 5 mg tablets (Lot N02640, expiring 08/2027) because some blister packages are not properly sealed. Defective packaging could allow the medication to degrade or become contaminated. No injuries have been reported.
ModerateFDAMar 11, 2026